Delhi High Court reprimands patent office over opposition procedures
Gilead will get another chance to defend its Sovaldi application after an Indian court found that the patent office’s handling constituted a “violation of the principles of natural justice”
Last week, the Delhi High Court issued a writ instructing the patent office to reconsider Gilead’s patent application (India patent application no 6087/DELNP/2005) for its Sovaldi hepatitis C drug. The Court found that the patent office improperly handled two oppositions...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.